Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Sarmento-Ribeiro, Ana Bela
[Clear All Filters]
2024
Marto CMiguel
,
Laranjo M
,
Gonçalves ACristina
,
Paula A
,
Jorge J
,
Caetano-Oliveira R
,
Sousa MInes
,
Oliveiros B
,
Ramalho-Santos J
,
Sarmento-Ribeiro ABela
, et al.
In Vitro Characterization of Reversine-Treated Gingival Fibroblasts and Their Safety Evaluation after In Vivo Transplantation.
Pharmaceutics. 2024;16(2).
PubMed
Google Scholar
2019
Assaraf YG
,
Brozovic A
,
Gonçalves ACristina
,
Jurkovicova D
,
Linē A
,
Machuqueiro M
,
Saponara S
,
Sarmento-Ribeiro ABela
,
Xavier CPR
,
M Vasconcelos H
.
The multi-factorial nature of clinical multidrug resistance in cancer.
Drug Resist Updat. 2019;46:100645.
PubMed
Google Scholar
2018
Balça-Silva J
,
Carmo Ado
,
Tão H
,
Rebelo O
,
Barbosa M
,
Moura-Neto V
,
Sarmento-Ribeiro ABela
,
Lopes MCeleste
,
Moreira JNuno
.
Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
Exp Cell Res. 2018.
PubMed
Google Scholar